<DOC>
	<DOCNO>NCT00625495</DOCNO>
	<brief_summary>The purpose study examine effect Nexium dose 40mg administer orally compare intravenously maximum acid output subject symptoms Gastroesophageal reflux disease ( GERD ) .</brief_summary>
	<brief_title>Study Comparing Effects Esomeprazole Adminstered Orally Intravenously Basal Pentrigastrin-stimulated Acid Output Subjects With Symptoms Gastroesophageal Reflux Disease ( GERD )</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Heartburn 2 last 7 day prior screen diagnosis GERD ( without diagnosis Erosive eosphagitis ) . Body Mass Index within limit specify protocol History esophageal , duodenal gastric surgery History severe liver disease . Any significant disease pathology judge clinically significant investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Gastroesophageal reflux disease</keyword>
	<keyword>Nexium</keyword>
	<keyword>Esomeprazole</keyword>
	<keyword>Administration method .</keyword>
</DOC>